- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Karen van Caulil Discusses Employers' Concerns About Rising Cancer Costs
The cost of oncology care has increased significantly in recent years, leading employers to worry about how they can provide consistent benefits for employees with cancer and their family members, according to Karen van Caulil, PhD, president and CEO of the Florida Health Care Coalition.
The cost of oncology care has increased significantly in recent years, leading employers to worry about how they can provide consistent benefits for employees with cancer and their family members, according to Karen van Caulil, PhD, president and CEO of the Florida Health Care Coalition.
Transcript (slightly modified)
What do employers view as the biggest challenge with oncology care?
Well, the cost and quality go hand in hand, but I would have to say that the top concern is the cost. We’ve been looking at the cost of care for cancer patients and we took some data recently from 2010, 2011, and 2012 and averaged it; and 2013, 2014, and 2015 and averaged it, and saw an overall increase of 70% in the cost of medical and pharmaceutical expenses for cancer patients.
It was about 62% increase for breast cancer patients, I think 65% for prostate cancer patients, so that has to top the list in terms of concerns because it’s really, with the trajectory of the cost increase, a lot of employers are really concerned about being able to provide the rich benefits that they have for so long for their employees and their family members.
A Look at the Legal and Legislative Landscape Impacting Drug Costs for Patients
October 23rd 2024Kimberly Westrich, MA, of National Pharmaceutical Council, and Adam Colborn, JD, of AMCP, run through the current status of lawsuits and lawmaking at the federal and state levels related to pharmacy benefit managers and cost-shifting programs.
Read More
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
The Latest in New and Emerging Therapies in Schizophrenia: Dr Megan Ehret
October 22nd 2024In addition to Cobenfy being approved for schizophrenia, there are other drugs with novel mechanisms being studied that may mean combination therapies or, at least, more options for patients in the future.
Read More
